Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.prismmedico.in | |
Market Cap | 27.04 Cr. | |
Enterprise Value(EV) | Cr. | - |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.52 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 24.86 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 20.54 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.17 | Calculated using Price: 44.60 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.61 Cr. | 6,063,428 Shares |
FaceValue | 10 | |
Company Profile | ||
The main object of the company was to carry on the trading in goods and commodities.. During the year ended March 31, 2008 the company earned Interest Income from loans and advances given and is presently engaged in the investing in shares and other securities and other financing activities. |
1 Day |
|
+4.94% |
1 Week |
|
+17.99% |
1 Month |
|
+48.47% |
3 Month |
|
+305.45% |
6 Month |
|
+421.64% |
1 Year |
|
+260.26% |
2 Year |
|
+70.23% |
5 Year |
|
+17.06% |
10 Year |
|
+130.49% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -3.03 | -0.55 | -0.51 | -3.15 | -0.15 | 2.85 | -0.38 | -1.00 | -2.90 | |
Return on Capital Employed (%) | -2.94 | -0.55 | -0.49 | -3.11 | 0.37 | 2.26 | -0.52 | -1.35 | -3.91 | |
Return on Assets (%) | -2.94 | -0.54 | -0.47 | -3.05 | -0.15 | 2.47 | -0.26 | -0.60 | -2.18 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2 | 2 | 2 | 13 | 13 | 13 | 13 | 13 | 13 | 12 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | ||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 4 | 9 | 9 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 2 | 2 | 2 | 13 | 13 | 17 | 22 | 21 | 12 | 12 | |
Non Curr. Assets | 0 | 0 | 10 | 11 | 10 | 2 | 2 | 0 | 1 | ||
Curr. Assets | 2 | 2 | 2 | 3 | 2 | 7 | 20 | 19 | 12 | 12 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2 | 2 | 2 | 13 | 13 | 17 | 22 | 21 | 12 | 12 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 0 | 0 | 21 | 36 | 27 | 17 | 8 | 8 | |||
Other Income | 0 | 0 | 0 | 0 | |||||||
Total Income | 0 | 0 | 0 | 21 | 37 | 27 | 17 | 8 | 8 | ||
Total Expenditure | 0 | 0 | 0 | 0 | -21 | -36 | -27 | -17 | -9 | -9 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Interest | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -1 | -1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | -1 | -1 | -4 | 0 | -2 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 1 | 4 | 0 | 2 | |||
Cash Fr. Finan. | 0 | 0 | 1 | 0 | |||||||
Net Change | 0 | 1 | 1 | 0 | 0 | 0 | 0 | ||||
Cash & Cash Eqvt | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
Mon, 23 Jan 2023
Non-Applicability Of Regulation 27 On Corporate Governance Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 31St December 2022. Dear Sir / Madam With reference to the above captioned subject it is hereby informed that the provisions of Regulation 27 on Corporate Governance of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 are not applicable on the company for the quarter ended 31st December 2022. You are requested to kindly take the same on your record and acknowledge receipt.Thanking You. |
Mon, 16 Jan 2023
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Dear Sir / Madam With reference to the above captioned subject report on investor complaints for the quarter ended 31st December 2022 is attached herewith. You are requested to kindly take the same on your record and acknowledge receipt.Thanking You. |
Sat, 14 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Dear Sir/Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 we hereby furnish a copy of compliance certificate issued by the RTA for the quarter ended 31st December 2022. You are requested to kindly take the same on your record and acknowledge receipt.Thanking You. |
Fri, 27 Jan 2023 |
|
|
|
|
|